Skip Nav Destination
Issues
January 2018
-
Cover Image
Cover Image
Cover: Heart Painting. Credit: Stella Levi. For more information, please visit istockphoto.com.
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0149-5992
EISSN 1935-5548
In this Issue
In This Issue
In This Issue of Diabetes Care
Diabetes Care December 2017, Vol.41, 1-2. doi:https://doi.org/10.2337/dc18-ti01
Editor’s Commentary
Perspectives in Care
Commentary
Heart Failure: The Most Important, Preventable, and Treatable Cardiovascular Complication of Type 2 Diabetes
Diabetes Care December 2017, Vol.41, 11-13. doi:https://doi.org/10.2337/dci17-0052
Diabetes Care Expert Forum
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors’ Expert Forum
William T. Cefalu; Sanjay Kaul; Hertzel C. Gerstein; Rury R. Holman; Bernard Zinman; Jay S. Skyler; Jennifer B. Green; John B. Buse; Silvio E. Inzucchi; Lawrence A. Leiter; Itamar Raz; Julio Rosenstock; Matthew C. Riddle
Diabetes Care December 2017, Vol.41, 14-31. doi:https://doi.org/10.2337/dci17-0057
Clinical Care / Education / Nutrition / Psychosocial Research
Severity of Neuropathy Is Associated With Long-term Spinal Cord Stimulation Outcome in Painful Diabetic Peripheral Neuropathy: Five-Year Follow-up of a Prospective Two-Center Clinical Trial
Maarten van Beek; José W. Geurts; Rachel Slangen; Nicolaas C. Schaper; Catharina G. Faber; Elbert A. Joosten; Carmen D. Dirksen; Robert T. van Dongen; Sander M.J. van Kuijk; Maarten van Kleef
Diabetes Care November 2017, Vol.41, 32-38. doi:https://doi.org/10.2337/dc17-0983
Epidemiology / Health Services Research
Prospective Postmarketing Surveillance of Acute Myocardial Infarction in New Users of Saxagliptin: A Population-Based Study
Sengwee Toh; Marsha E. Reichman; David J. Graham; Christian Hampp; Rongmei Zhang; Melissa G. Butler; Aarthi Iyer; Malcolm Rucker; Madelyn Pimentel; Jack Hamilton; Samuel Lendle; Bruce H. Fireman; Mini-Sentinel Saxagliptin-AMI Surveillance Writing Group
Diabetes Care November 2017, Vol.41, 39-48. doi:https://doi.org/10.2337/dc17-0476
Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses—A Population-Based and Propensity-Matched Cohort Study
Eric Yuk Fai Wan; Colman Siu Cheung Fung; Fang Fang Jiao; Esther Yee Tak Yu; Weng Yee Chin; Daniel Yee Tak Fong; Carlos King Ho Wong; Anca Ka Chun Chan; Karina Hiu Yen Chan; Ruby Lai Ping Kwok; Cindy Lo Kuen Lam
Diabetes Care November 2017, Vol.41, 49-59. doi:https://doi.org/10.2337/dc17-0426
Prediction of Type 2 Diabetes by Hemoglobin A1c in Two Community-Based Cohorts
Aaron Leong; Natalie Daya; Bianca Porneala; James J. Devlin; Dov Shiffman; Michael J. McPhaul; Elizabeth Selvin; James B. Meigs
Diabetes Care October 2017, Vol.41, 60-68. doi:https://doi.org/10.2337/dc17-0607
Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes
Diabetes Care November 2017, Vol.41, 69-78. doi:https://doi.org/10.2337/dc17-1414
N-Glycan Profile and Kidney Disease in Type 1 Diabetes
Mairead L. Bermingham; on behalf of the SDRN Type 1 Bioresource Investigators; Marco Colombo; on behalf of the SDRN Type 1 Bioresource Investigators; Stuart J. McGurnaghan; on behalf of the SDRN Type 1 Bioresource Investigators; Luke A.K. Blackbourn; on behalf of the SDRN Type 1 Bioresource Investigators; Frano Vučković; on behalf of the SDRN Type 1 Bioresource Investigators; Maja Pučić Baković; on behalf of the SDRN Type 1 Bioresource Investigators; Irena Trbojević-Akmačić; on behalf of the SDRN Type 1 Bioresource Investigators; Gordan Lauc; on behalf of the SDRN Type 1 Bioresource Investigators; Felix Agakov; on behalf of the SDRN Type 1 Bioresource Investigators; Anna S. Agakova; on behalf of the SDRN Type 1 Bioresource Investigators; Caroline Hayward; on behalf of the SDRN Type 1 Bioresource Investigators; Lucija Klarić; on behalf of the SDRN Type 1 Bioresource Investigators; Colin N.A. Palmer; on behalf of the SDRN Type 1 Bioresource Investigators; John R. Petrie; on behalf of the SDRN Type 1 Bioresource Investigators; John Chalmers; on behalf of the SDRN Type 1 Bioresource Investigators; Andrew Collier; on behalf of the SDRN Type 1 Bioresource Investigators; Fiona Green; on behalf of the SDRN Type 1 Bioresource Investigators; Robert S. Lindsay; on behalf of the SDRN Type 1 Bioresource Investigators; Sandra Macrury; on behalf of the SDRN Type 1 Bioresource Investigators; John A. McKnight; on behalf of the SDRN Type 1 Bioresource Investigators; Alan W. Patrick; on behalf of the SDRN Type 1 Bioresource Investigators; Sandeep Thekkepat; on behalf of the SDRN Type 1 Bioresource Investigators; Olga Gornik; on behalf of the SDRN Type 1 Bioresource Investigators; Paul M. McKeigue; on behalf of the SDRN Type 1 Bioresource Investigators; Helen M. Colhoun; on behalf of the SDRN Type 1 Bioresource Investigators
Diabetes Care November 2017, Vol.41, 79-87. doi:https://doi.org/10.2337/dc17-1042
Diabetes Care Disparities in Long-standing Type 1 Diabetes in Canada and the U.S.: A Cross-sectional Comparison
Alanna Weisman; Leif E. Lovblom; Hillary A. Keenan; Liane J. Tinsley; Stephanie D’Eon; Genevieve Boulet; Mohammed A. Farooqi; Julie A. Lovshin; Andrej Orszag; Yuliya Lytvyn; Michael H. Brent; Narinder Paul; Vera Bril; David Z. Cherney; Bruce A. Perkins
Diabetes Care November 2017, Vol.41, 88-95. doi:https://doi.org/10.2337/dc17-1074
The Effect of Telemedicine Follow-up Care on Diabetes-Related Foot Ulcers: A Cluster-Randomized Controlled Noninferiority Trial
Hilde Smith-Strøm; Jannicke Igland; Truls Østbye; Grethe S. Tell; Marie F. Hausken; Marit Graue; Svein Skeie; John G. Cooper; Marjolein M. Iversen
Diabetes Care November 2017, Vol.41, 96-103. doi:https://doi.org/10.2337/dc17-1025
The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes
Alexandra K. Lee; Bethany Warren; Clare J. Lee; John W. McEvoy; Kunihiro Matsushita; Elbert S. Huang; A. Richey Sharrett; Josef Coresh; Elizabeth Selvin
Diabetes Care November 2017, Vol.41, 104-111. doi:https://doi.org/10.2337/dc17-1669
Pathophysiology / Complications
Hyperbaric Oxygen Therapy in the Treatment of Ischemic Lower- Extremity Ulcers in Patients With Diabetes: Results of the DAMO2CLES Multicenter Randomized Clinical Trial
Katrien T.B. Santema; Robert M. Stoekenbroek; Mark J.W. Koelemay; Jim A. Reekers; Laura M.C. van Dortmont; Arno Oomen; Luuk Smeets; Jan J. Wever; Dink A. Legemate; Dirk T. Ubbink; DAMO2CLES Study Group
Diabetes Care October 2017, Vol.41, 112-119. doi:https://doi.org/10.2337/dc17-0654
Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes
Clare B. Kelly; Michelle B. Hookham; Jeremy Y. Yu; Alicia J. Jenkins; Alison J. Nankervis; Kristian F. Hanssen; Satish K. Garg; James A. Scardo; Samar M. Hammad; M. Kathryn Menard; Christopher E. Aston; Timothy J. Lyons
Diabetes Care November 2017, Vol.41, 120-127. doi:https://doi.org/10.2337/dc17-1635
Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes
Nathaniel L. Baker; Kelly J. Hunt; Danielle R. Stevens; Gabor Jarai; Glenn D. Rosen; Richard L. Klein; Gabriel Virella; Maria F. Lopes-Virella; the DCCT/EDIC Research Group
Diabetes Care November 2017, Vol.41, 128-135. doi:https://doi.org/10.2337/dc17-0867
Mortality Reduction Associated With β-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes
Klaus K. Witte; Michael Drozd; Andrew M.N. Walker; Peysh A. Patel; Jessica C. Kearney; Sally Chapman; Robert J. Sapsford; John Gierula; Maria F. Paton; Judith Lowry; Mark T. Kearney; Richard M. Cubbon
Diabetes Care October 2017, Vol.41, 136-142. doi:https://doi.org/10.2337/dc17-1406
Cardiovascular and Metabolic Risk
Short- and Long-term Prognosis of Patients With Acute Heart Failure With and Without Diabetes: Changes Over the Last Three Decades
Jan C. van den Berge; Alina A. Constantinescu; Hendrik J. Boiten; Ron T. van Domburg; Jaap W. Deckers; K. Martijn Akkerhuis
Diabetes Care October 2017, Vol.41, 143-149. doi:https://doi.org/10.2337/dc17-0544
The Prognostic Significance of Diabetes and Microvascular Complications in Patients With Heart Failure With Preserved Ejection Fraction
Pratik B. Sandesara; Wesley T. O’Neal; Heval M. Kelli; Ayman Samman-Tahhan; Muhammad Hammadah; Arshed A. Quyyumi; Laurence S. Sperling
Diabetes Care October 2017, Vol.41, 150-155. doi:https://doi.org/10.2337/dc17-0755
Cardiovascular Complications Over 5 Years and Their Association With Survival in the GERODIAB Cohort of Elderly French Patients With Type 2 Diabetes
Bernard Bauduceau; Jean-Pierre Le Floch; Serge Halimi; Christiane Verny; Jean Doucet; the SFD/SFGG Intergroup
Diabetes Care November 2017, Vol.41, 156-162. doi:https://doi.org/10.2337/dc17-1437
Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON
Min Jun; on behalf of the ADVANCE Collaborative Group; Toshiaki Ohkuma; on behalf of the ADVANCE Collaborative Group; Sophia Zoungas; on behalf of the ADVANCE Collaborative Group; Stephen Colagiuri; on behalf of the ADVANCE Collaborative Group; Giuseppe Mancia; on behalf of the ADVANCE Collaborative Group; Michel Marre; on behalf of the ADVANCE Collaborative Group; David Matthews; on behalf of the ADVANCE Collaborative Group; Neil Poulter; on behalf of the ADVANCE Collaborative Group; Bryan Williams; on behalf of the ADVANCE Collaborative Group; Anthony Rodgers; on behalf of the ADVANCE Collaborative Group; Vlado Perkovic; on behalf of the ADVANCE Collaborative Group; John Chalmers; on behalf of the ADVANCE Collaborative Group; Mark Woodward; on behalf of the ADVANCE Collaborative Group
Diabetes Care October 2017, Vol.41, 163-170. doi:https://doi.org/10.2337/dc17-1467
Enhanced Predictive Capability of a 1-Hour Oral Glucose Tolerance Test: A Prospective Population-Based Cohort Study
Manan Pareek; Deepak L. Bhatt; Mette L. Nielsen; Ram Jagannathan; Karl-Fredrik Eriksson; Peter M. Nilsson; Michael Bergman; Michael H. Olsen
Diabetes Care November 2017, Vol.41, 171-177. doi:https://doi.org/10.2337/dc17-1351
FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes
Gary C. Chan; Jasmin Divers; Gregory B. Russell; Carl D. Langefeld; Lynne E. Wagenknecht; Fang-Chi Hsu; Jianzhao Xu; S. Carrie Smith; Nicholette D. Palmer; Pamela J. Hicks; Donald W. Bowden; Thomas C. Register; Lijun Ma; J. Jeffrey Carr; Barry I. Freedman
Diabetes Care November 2017, Vol.41, 178-186. doi:https://doi.org/10.2337/dc17-0820
Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients
Fernando Bril; Paola Portillo-Sanchez; I-Chia Liu; Srilaxmi Kalavalapalli; Kristin Dayton; Kenneth Cusi
Diabetes Care November 2017, Vol.41, 187-192. doi:https://doi.org/10.2337/dc17-1349
Review
Disparities in Environmental Exposures to Endocrine-Disrupting Chemicals and Diabetes Risk in Vulnerable Populations
Diabetes Care November 2017, Vol.41, 193-205. doi:https://doi.org/10.2337/dc16-2765
Issues and Events
e-Letters
Observations
Monocyte DPP4 Expression in Human Atherosclerosis Is Associated With Obesity and Dyslipidemia
Xiaoquan Rao; Jeffrey A. Deiuliis; Georgeta Mihai; Juliet Varghese; Chang Xia; Matthew B. Frieman; Carole Sztalryd; Xiao Jian Sun; Michael J. Quon; Simeon I. Taylor; Sanjay Rajagopalan; Jixin Zhong
Diabetes Care November 2017, Vol.41, e1-e3. doi:https://doi.org/10.2337/dc17-0672
Empagliflozin and Assessment of Lower-Limb Amputations in the EMPA-REG OUTCOME Trial
Diabetes Care November 2017, Vol.41, e4-e5. doi:https://doi.org/10.2337/dc17-1551
Comments and Responses
Comment on Dubois-Laforgue et al. Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (HNF1B) Molecular Defects. Diabetes Care 2017;40:1436–1443
Diabetes Care December 2017, Vol.41, e7. doi:https://doi.org/10.2337/dc17-1672
Response to Comment on Dubois-Laforgue et al. Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (HNF1B) Molecular Defects. Diabetes Care 2017;40:1436–1443
Danièle Dubois-Laforgue; Erika Cornu; Cécile Saint-Martin; Joël Coste; Christine Bellanné-Chantelot; José Timsit
Diabetes Care December 2017, Vol.41, e8-e9. doi:https://doi.org/10.2337/dci17-0048
